AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glimitoss M 2mg/500mg Tablet SR

Prescription Icon
Prescription Required

Marketer

Minitoss Medicines

Salt Composition

Glimepiride (2mg) + Metformin (500mg)

Overview Glimitoss M 2mg/500mg Tablet SR

Diabetol Duo 2mg/500mg Extended-Release Tablets are classified as antidiabetic medications. This dual-action formulation treats type 2 diabetes in adults by managing blood glucose levels. Diabetol Duo should be ingested with meals, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continued use is crucial, even with controlled blood sugar, as discontinuation without medical supervision can elevate glucose levels, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. Remember, this medication is part of a comprehensive diabetes management plan encompassing a healthy diet, regular physical activity, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is a common side effect, characterized by sweating, dizziness, headache, and tremors. Learn to recognize these symptoms and carry a fast-acting glucose source, like sugary snacks or juice. Alcohol consumption increases hypoglycemia risk and should be limited. Other potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Individuals with a history of heart disease should inform their physician before initiating treatment. Pregnant or breastfeeding individuals require medical consultation prior to use. Regular blood glucose monitoring and periodic blood tests to assess blood cell counts and liver function are recommended.

Primary Ingredients of Glimitoss M 2mg/500mg Tablet SR

No information provided. Please provide the text you wish me to rephrase.

Uses of Glimitoss M 2mg/500mg Tablet SR

Managing type 2 diabetes

Major Benefits of Glimitoss M 2mg/500mg Tablet SR:

Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consume Glimitoss M 2mg/500mg Extended-Release tablets with food.

Common Side effects of Glimitoss M 2mg/500mg Tablet SR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glimitoss M 2mg/500mg Tablet SR:

Follow your physician's instructions precisely regarding dosage and treatment length for this medication. Ingest the Glimitoss M 2mg/500mg Tablet SR whole; do not crush, chew, or divide the tablet. Administer this medication with food.

How Glimitoss M 2mg/500mg Tablet SR works:

Glimepiride/Metformin 2mg/500mg extended-release tablets (Glimitoss M) combine two antidiabetic agents. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose uptake, and enhancing insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol alongside Glimitoss M 2mg/500mg SR tablets is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Glimitoss M 2mg/500mg SR tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the unborn child. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Extended-release Glimitoss M tablets (2mg/500mg) are contraindicated for breastfeeding mothers. Evidence indicates potential infant harm from this medication.

DrivingDrivingCAUTION

Driving may be impaired by excessively low or high blood sugar levels. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

Patients with kidney impairment should use Glimitoss M 2mg/500mg SR tablets cautiously, potentially requiring dosage modification. Consult your physician. Glimitoss M 2mg/500mg SR tablets are contraindicated in those with severe kidney disease. Regular kidney function monitoring is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Glimitoss M 2mg/500mg Tablet SR cautiously, potentially requiring dosage modification. Medical advice is essential. For those with mild to moderate liver disease, a low initial dose is typically prescribed; however, its use is contraindicated in patients with severe hepatic dysfunction.

What if you forget to take Glimitoss M 2mg/500mg Tablet SR :

Should you forget a Glimitoss M 2mg/500mg Tablet SR dose, administer it promptly. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Glimitoss M 2mg/500mg Tablet SR

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Glimitoss M 2mg/500mg Tablet SR

Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Glimitoss M 2mg/500mg Tablet SR can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare but potentially harmful side effect is more likely in patients with kidney disease, older adults, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these symptoms, discontinue Glimitoss M and seek immediate medical attention.
Glimitoss M 2mg/500mg SR tablets combine glimepiride and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It is not suitable for type 1 diabetes.
Glimitoss M 2mg/500mg SR Tablets may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Prolonged use of Glimitoss M 2mg/500mg SR tablets can lead to vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency, if left untreated, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary difficulties, cognitive changes, and balance problems (ataxia). To mitigate this risk, supplemental vitamin B12 intake, at least annually, is recommended by some researchers.
Glimitoss M 2mg/500mg SR Tablets can cause hypoglycemia (low blood sugar). Symptoms include nausea, headache, irritability, hunger, sweating, dizziness, rapid heart rate, and anxiety or shakiness. Hypoglycemia risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Combining Glimitoss M 2mg/500mg SR tablets with alcohol is unsafe. This combination can cause dangerously low blood sugar (hypoglycemia) and increase the risk of lactic acidosis.
Glimitoss M 2mg/500mg Tab...
52
MRP 60
13% off